109 related articles for article (PubMed ID: 1243666)
1. [Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)].
Jäger W; Scharrer I; Satkowski U; Breddin K
Arzneimittelforschung; 1975; 25(12):1938-44. PubMed ID: 1243666
[TBL] [Abstract][Full Text] [Related]
2. [The effect of bencyclan on shear induced platelet aggregation (author's transl)].
Klose HJ; Rieger H; Schmid-Schönbein H
Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function.
Ponari O; Civardi E; Dettori G; Magha A; Potì R; Bulletti G
Arzneimittelforschung; 1976; 26(8):1532-8. PubMed ID: 12770
[TBL] [Abstract][Full Text] [Related]
4. Study of platelet aggregation in vivo i. Effect of bencyclan.
Ambrus JL; Ambrus CM; Gastpar H; Sapvento PJ; Weber FJ; Thurber LE
J Med; 1976; 7(6):439-47. PubMed ID: 827596
[TBL] [Abstract][Full Text] [Related]
5. [Effect of bencyclan and theophylline on changes of platelet aggregation and factor 3 activity].
Losonczy H; Nagy I; Szaksz I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):853-60. PubMed ID: 94878
[TBL] [Abstract][Full Text] [Related]
6. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
Resag K; Melzer G; Nitz RE
Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
[TBL] [Abstract][Full Text] [Related]
7. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells.
Gastpar H; Ambrus J; Thurber LE
J Med; 1977; 8(1):53-6. PubMed ID: 267156
[TBL] [Abstract][Full Text] [Related]
8. [Blood circulation, oxygen pressure and pH of the cerebral cortex under the influence of bencyclane].
Gärtner E; Enzenross HG; Vlahov V; Schanzenbächer P; Brandt H; Betz E
Arzneimittelforschung; 1975 Jun; 25(6):887-91. PubMed ID: 240368
[TBL] [Abstract][Full Text] [Related]
9. Proceedings: The effect on benzcyclan and theophyllin on the ADP induced platelet aggregation in vitro and vivo.
Losonczy H; Nagy I; Gregus Z; Szaksz I
Thromb Diath Haemorrh; 1975 Sep; 34(1):336. PubMed ID: 1188766
[No Abstract] [Full Text] [Related]
10. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
11. [The mechanism of action of bencyclane on smooth musculature].
Kukovetz WR; Pöch G; Holzmann S; Paietta E
Arzneimittelforschung; 1975 May; 25(5):722-6. PubMed ID: 170943
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human platelet function by parsalmide.
Fantasia R; Colombi M; Della Volpe A; Pogliani EM
Arzneimittelforschung; 1982; 32(10):1312-4. PubMed ID: 6897511
[TBL] [Abstract][Full Text] [Related]
13. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydergine, bencyclane and isoxsuprine on the rabbit platelet aggregation.
Takano S; Sato K; Nemoto H; Suzuki T
Fukushima J Med Sci; 1982 Dec; 29(1-2):19-23. PubMed ID: 7186874
[No Abstract] [Full Text] [Related]
15. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
16. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
Walter E; Weber E
Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
[TBL] [Abstract][Full Text] [Related]
17. [Decrease of disaccharidase activity following application of bencyclan-hydrogenfumarate (author's transl)].
Frisius H; Al-Abadi H; Heidrich H
Klin Wochenschr; 1976 Sep; 54(18):895-7. PubMed ID: 966636
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of ticlopidine: relation between dose and time of administration to platelet inhibition.
Kuzniar J; Splawinska B; Malinga K; Mazurek AP; Splawinski J
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):357-61. PubMed ID: 8864800
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
20. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
